Variable | Frequency (%) N = 56 | Median pharmaceutical formulation score [interquartile range] | p-value | Median pharmaceutical Nano-formulation score [interquartile range] | p-value | P-value between the median of pharmacutical formulation and nanoformulation |
---|---|---|---|---|---|---|
Gender | ||||||
Male | 20 (35.7) | 4.0 [3.25–4.00] | 0.157a | 2.5 [1.25–3.00] | 0.159 a | < 0.001a |
Female | 36 (64.3) | 3.0 [3.00–4.00] | 1.0 [0.25–3.00] | < 0.001a | ||
Type of Hospital | ||||||
Governmental | 29 (51.8) | 3.0 [2.50–4.00] | 0.515b | 2.0 [1.00–3.00] | 0.579 b | < 0.001a |
Private | 16 (28.6) | 4.0 [3.00–4.00] | 1.5 [1.00–3.00] | < 0.001a | ||
NGOs | 11 (19.6) | 4.0 [2.00–4.00] | 1.0 [0.00–3.00] | 0.007a | ||
Education level | ||||||
Bachelor | 49 (87.5) | 4.0 [3.00–4.00] | 0.92 a | 2.0 [0.50–3.00] | 0.092 a | < 0.001a |
Master | 7 (12.5) | 4.0 [3.00–4.00] | 3.0 [1.00–3.00] | 0.117a | ||
Graduation university | ||||||
Local Universities | 40 (71.4) | 3.0 [2.25–4.00] | 0.018 a | 2.0 [0.25–3.00] | 0.390 a | < 0.001a |
International Universities | 16 (28.6) | 4.0 [4.00–4.00] | 2.0 [1.00–3.00] | < 0.001a | ||
Experience (years) | ||||||
0–5 | 25 (44.6) | 3.0 [2.50–4.00] | 0.139 b | 2.0 [1.00–3.00] | 0.920 b | < 0.001a |
5–10 | 14 (25.0) | 4.0 [3.75–4.00] | 2.0 [1.00–3.00] | < 0.001a | ||
> 10 | 17 (30.4) | 3.5 [2.50–4.00] | 1.0 [0.00–3.00] | 0.001a |